Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy-Reference-Cited by-同舟云学术

Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy

Published:2022-11 Issue:11 Volume:129 Page:1287-1293
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Kessel Line^ORCID,Christensen Ulrik Correll,Klemp Kristian

Publisher

Elsevier BV

Subject

Ophthalmology

Reference12 articles.

1. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom;Pontikos;Ophthalmology,2020

2. Inherited retinal diseases: therapeutics, clinical trials and end points—A review;Georgiou;Clin Exp Ophthalmol,2021

3. The natural history of inherited retinal dystrophy due to biallelic mutations in the RPE65 gene;Chung;Am J Ophthalmol,2019

4. Voretigene neparvovec in patients with RPE65 mutation-associated inherited retinal dystrophy: baseline characteristics from the real-world, prospective, observational PERCEIVE study;Fischer;Invest Ophthalmol Vis Sci,2021

5. Perifoveal chorioretinal atrophy after subretinal Voretigene Neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis;Gange;Ophthalmol Retina,2022

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial;Nature Communications;2024-09-10

2. Dose-Dependent Progression of Chorioretinal Atrophy at the Injection Site After Subretinal Injection of rAAV2/8 in Nonhuman Primates;Ophthalmology Science;2024-09

3. An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study;Human Gene Therapy;2024-08-01

4. Myopic Macular Hole and Detachment after Gene Therapy in Atypical RPE65 Retinal Dystrophy: A Case Report;Genes;2024-07-04

5. Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice;Ophthalmology Retina;2024-07